Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Aug 7, 2024, before the open
10-Q filed Aug 7, 2024, 38 days after period end · 0001628280-24-035636
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $6.18M | $6.20M | $3.44M | $0.00 |
| Net Income | -$14.58M | -$17.97M | -$18.27M | -$1.54M |
| EPS Diluted |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| -$0.54 |
| -$0.67 |
| -$0.87 |
| -$0.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.